Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

A Facebook video that cobbles together unrelated footage of two celebrities to promote a purported cure for lung diseases isn’t authentic, despite the post’s claim that chronic obstructive pulmonary ...

Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Those suffering from severe asthma, upper respiratory tract disease, Chronic Obstructive Pulmonary Disease (COPD), Asbestosis ...

The following is a summary of “Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data ...

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...

Chronic pulmonary aspergillosis (CPA) is a collection of progressive diseases of the lung caused by infection with members of the Aspergillus genus. The five subtypes of CPA are aspergilloma, ...